NCT04637633View on ClinicalTrials.gov

Topical Cyclosporine-A for Management of Epiphora

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

November 1, 2020

Conditions
Epiphora
Interventions
DRUG

topical 0.05% CsA (Restasis®, Allergan Inc, Irvine, California)twice daily dose,

topical preservative free artificial tears Q.I. D.

Trial Locations (1)

Unknown

Farwanyia Hospital, Kuwait City

All Listed Sponsors
lead

Farwaniya Hospital

OTHER_GOV

NCT04637633 - Topical Cyclosporine-A for Management of Epiphora | Biotech Hunter | Biotech Hunter